Superior vena cava (SVC) syndrome is a spectrum of potentially life-threatening clinical manifestations resulting from either partial or complete obstruction of central venous blood flow. Approximately 70% of cases are caused by malignancy. The primary treatment end point for SVC syndrome is the achievement of long-term patency of the SVC. Malignant SVC syndrome is managed by either radiation therapy, open surgical intervention, or endovascular therapy with angioplasty and stenting. The current report describes an uncommon case of nonmalignant SVC syndrome resulting from complications of hemodialysis catheters that was managed with open revascularization between the right internal jugular and brachiocephalic veins and the right atrium.
Keyphrases
- vena cava
- inferior vena cava
- radiation therapy
- blood flow
- case report
- randomized controlled trial
- chronic kidney disease
- squamous cell carcinoma
- minimally invasive
- ultrasound guided
- risk factors
- acute coronary syndrome
- coronary artery disease
- coronary artery
- pulmonary embolism
- radiation induced
- end stage renal disease
- bone marrow
- left atrial appendage
- atrial fibrillation
- replacement therapy
- catheter ablation
- cell therapy